Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1373-1381

  Guichelaar, Teun ^a   Ten Brink, Corlinda B ^a   Van Kooten, Peter J ^a   Berlo, Suzanne E ^a   Broeren, Chris P ^a   Van Eden, Willem ^a   Broere, Femke ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; OVALBUMIN; PROTEOGLYCAN; SUPPRESSOR FACTOR; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CHRONIC ARTHRITIS; CONTROLLED STUDY; DISEASE COURSE; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; CARTILAGE; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; RETROVIRUS; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; CARTILAGE; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; CYTOKINES; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PROTEOGLYCANS; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 40749155409     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1373     Document Type: Article

References (57)

1. Bluestone, J. A. 2005. Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol. 5: 343-349.
2. Tarner, I. H., A. J. Slavin, J. McBride, A. Levicnik, R. Smith, G. P. Nolan, C. H. Contag, and C. G. Fathman. 2003. Treatment of autoimmune disease by adoptive cellular gene therapy. Ann. NY Acad. Sci. 998: 512-519.
3. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
4. Rabinovich, G. A., G. Daly, H. Dreja, H. Tailor, C. M. Riera, J. Hirabayashi, and Y. Chernajovsky. 1999. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 190: 385-398.
5. Li, N. L., D. Q. Zhang, K. Y. Zhou, A. Cartman, J. Y. Leroux, A. R. Poole, and Y. P. Zhang. 2000. Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients. Cell Res. 10: 39-49.
6. ter Steege, J., M. Vianen, J. van Bilsen, J. Bijlsma, F. Lafeber, and M. Wauben. 2003. Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target. J. Rheumatol. 30: 1147-1156.
7. Stamenkovic, I., M. Stegagno, K. A. Wright, S. M. Krane, E. P. Amento, R. B. Colvin, R. J. Duquesnoy, and J. T. Kurnick. 1988. Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc. Natl. Acad. Sci. USA 85: 1179-1183.
8. Kobari, Y., Y. Misaki, K. Setoguchi, W. Zhao, Y. Komagata, K. Kawahata, Y. Iwakura, and K. Yamamoto. 2004. T cells accumulating in the inflamed joints of a spontaneous murine model of rheumatoid arthritis become restricted to common clonotypes during disease progression. Int. Immunol. 16: 131-138.
9. + Th1 cells in a syngeneic system. J. Immunol. 168: 6013-6021.
10. Berlo, S. E., P. J. van Kooten, C. B. Ten Brink, F. Hauet-Broere, M. A. Oosterwegel, T. T. Glant, W. Van Eden, and C. P. Broeren. 2005. Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation. J. Autoimmun. 25: 172-180.
11. Berlo, S. E., T. Guichelaar, C. B. Ten Brink, P. J. van Kooten, F. Hauet-Broere, K. Ludanyi, W. van Eden, C. P. Broeren, and T. T. Glant. 2006. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum. 54: 2423-2433.
12. Maffia, P., J. M. Brewer, J. A. Gracie, A. Ianaro, B. P. Leung, P. J. Mitchell, K. M. Smith, I. B. McInnes, and P. Garside. 2004. Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J. Immunol. 173: 151-156.
13. Osman, G. E., S. Cheunsuk, S. E. Allen, E. Chi, H. D. Liggitt, L. E. Hood, and W. C. Ladiges. 1998. Expression of a type II collagen-specific TCR transgene accelerates the onset of arthritis in mice. Int. Immunol. 10: 1613-1622.
14. O'Neill, S. K., M. J. Shlomchik, T. T. Glant, Y. Cao, P. D. Doodes, and A. Finnegan. 2005. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174: 3781-3788.
15. Chaiamnuay, S., and S. L. Bridges, Jr. 2005. The role of B cells and autoantibodies in rheumatoid arthritis. Pathophysiology 12: 203-216.
16. Brennan, F. R., K. Mikecz, E. I. Buzas, D. Ragasa, G. Cs-Szabo, G. Negroiu, and T. T. Glant. 1995. Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin. Exp. Immunol. 101: 414-421.
17. Takemura, S., P. A. Klimiuk, A. Braun, J. J. Goronzy, and C. M. Weyand. 2001. T cell activation in rheumatoid synovium is B cell dependent. J. Immunol. 167: 4710-4718.
18. Mason, D., and F. Powrie. 1998. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10: 649-655.
19. Mills, K. H., and P. McGuirk. 2004. Antigen-specific regulatory T cells-their induction and role in infection. Semin. Immunol. 16: 107-117.
20. von Herrath, M. G., and L. C. Harrison. 2003. Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3: 223-232.
21. O'Garra, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10: 801-805.
22. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2: 816-822.
23. Lohr, J., B. Knoechel, J. J. Wang, A. V. Villarino, and A. K. Abbas. 2006. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 203: 2785-2791.
24. Dong, C. 2006. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6: 329-333.
25. Anderson, A. C., J. Reddy, R. Nazareno, R. A. Sobel, L. B. Nicholson, and V. K. Kuchroo. 2004. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J. Immunol. 173: 828-834.
26. Finnegan, A., C. D. Kaplan, Y. Cao, H. Eibel, T. T. Glant, and J. Zhang. 2003. Collagen-induced arthritis is exacerbated in IL-10-deficient mice. Arthritis Res. Ther. 5: R18-R24.
27. Finnegan, A., K. Mikecz, P. Tao, and T. T. Glant. 1999. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J. Immunol. 163: 5383-5390.
28. Fellowes, R., C. J. Etheridge, S. Coade, R. G. Cooper, L. Stewart, A. D. Miller, and P. Woo. 2000. Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery. Gene Ther. 7: 967-977.
29. Kasama, T., R. M. Strieter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95: 2868-2876.
30. + T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum. 43: 617-627.
31. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
32. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
33. Asseman, C., and F. Powrie. 1998. Interleukin 10 is a growth factor for a population of regulatory T cells. Gut 42: 157-158.
34. Goodstone, N. J., M. C. Doran, R. N. Hobbs, R. C. Butler, J. J. Dixey, and B. A. Ashton. 1996. Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls. Ann. Rheum. Dis. 55: 40-46.
35. 1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum. 41: 1019-1025.
36. Glant, T. T., A. Finnegan, and K. Mikecz. 2003. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit. Rev. Immunol. 23: 199-250.
37. Hanyecz, A., S. E. Berlo, S. Szanto, C. P. Broeren, K. Mikecz, and T. T. Glant. 2004. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Arthritis Rheum. 50: 1665-1676.
38. + mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur. J. Immunol. 33: 2801-2810.
39. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617.
40. Kaplan, C., J. C. Valdez, R. Chandrasekaran, H. Eibel, K. Mikecz, T. T. Glant, and A. Finnegan. 2002. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res. 4: 54-58.
41. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J. Immunol. 172: 5213-5221.
42. Cobbold, S., and H. Waldmann. 1998. Infectious tolerance. Curr. Opin. Immunol. 10: 518-524.
43. Crawley, E., S. Kon, and P. Woo. 2001. Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis. Rheumatology 40: 574-578.
44. Asadullah, K., W. Sterry, and H. D. Volk. 2003. Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55: 241-269.
45. + T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. J. Immunol. 165: 6908-6914.
46. Nakajima, A., C. M. Seroogy, M. R. Sandora, I. H. Tarner, G. L. Costa, C. Taylor-Edwards, M. H. Bachmann, C. H. Contag, and C. G. Fathman. 2001. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J. Clin. Invest. 107: 1293-1301.
47. Setoguchi, K., Y. Misaki, Y. Araki, K. Fujio, K. Kawahata, T. Kitamura, and K. Yamamoto. 2000. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen. J. Immunol. 165: 5980-5986.
48. Wynn, T. A. 2005. Th-17: a giant step from Th1 and Th2. Nat. Immunol. 6: 1069-1070.
49. Lubberts, E., M. I. Koenders, and W. B. van den Berg. 2005. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7: 29-37.
50. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
51. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
52. Amadi-Obi, A., C. R. Yu, X. Liu, R. M. Mahdi, G. L. Clarke, R. B. Nussenblatt, I. Gery, Y. S. Lee, and C. E. Egwuagu. 2007. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13: 711-718.
53. Liew, F. Y. 2002. Th1 and Th2 cells: a historical perspective. Nat. Rev. Immunol. 2: 55-60.
54. Hollo, K., T. T. Glant, M. Garzo, A. Finnegan, K. Mikecz, and E. Buzas. 2000. Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin. Exp. Immunol. 120: 167-173.
55. Gerber, J. S., and D. M. Mosser. 2001. Stimulatory and inhibitory signals originating from the macrophage Fcγ receptors. Microbes Infect. 3: 131-139.
56. Kaplan, C. D., Y. Cao, J. S. Verbeek, M. Tunyogi-Csapo, and A. Finnegan. 2005. Development of proteoglycan-induced arthritis is critically dependent on Fcγ receptor type III expression. Arthritis Rheum. 52: 1612-1619.
57. Kaplan, C. D., S. K. O'Neill, T. Koreny, M. Czipri, and A. Finnegan. 2002. Development of inflammation in proteoglycan-induced arthritis is dependent on FcγR regulation of the cytokine/chemokine environment. J. Immunol. 169: 5851-5859.